Flint M - Search Results

1

Flint M, Tscherne DM. Flint M, et al. Methods Mol Biol. 2009;510:265-77. doi: 10.1007/978-1-59745-394-3_20. Methods Mol Biol. 2009. PMID: 19009268

2

Design and synthesis of HCV agents with sequential triple inhibitory potentials.

Zhu T, Fawzi MB, Flint M, Kong F, Szeliga J, Tsao R, Howe AY, Pan W. Zhu T, et al. Among authors: flint m. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5212-6. doi: 10.1016/j.bmcl.2010.06.156. Epub 2010 Jul 23. Bioorg Med Chem Lett. 2010. PMID: 20655214

3

Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).

Flint M, Mullen S, Deatly AM, Chen W, Miller LZ, Ralston R, Broom C, Emini EA, Howe AY. Flint M, et al. Antimicrob Agents Chemother. 2009 Feb;53(2):401-11. doi: 10.1128/AAC.01081-08. Epub 2008 Oct 20. Antimicrob Agents Chemother. 2009. PMID: 18936191 Free PMC article.

4

Diverse CD81 proteins support hepatitis C virus infection.

Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA. Flint M, et al. J Virol. 2006 Nov;80(22):11331-42. doi: 10.1128/JVI.00104-06. Epub 2006 Aug 30. J Virol. 2006. PMID: 16943299 Free PMC article.

5

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, Rice CM, McKeating JA. Hsu M, et al. Among authors: flint m. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6. doi: 10.1073/pnas.0832180100. Epub 2003 May 21. Proc Natl Acad Sci U S A. 2003. PMID: 12761383 Free PMC article.

6

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P. McKeating JA, et al. Among authors: flint m. J Virol. 2004 Aug;78(16):8496-505. doi: 10.1128/JVI.78.16.8496-8505.2004. J Virol. 2004. PMID: 15280458 Free PMC article.

7

Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins.

Flint M, Logvinoff C, Rice CM, McKeating JA. Flint M, et al. J Virol. 2004 Jul;78(13):6875-82. doi: 10.1128/JVI.78.13.6875-6882.2004. J Virol. 2004. PMID: 15194763 Free PMC article.

8

Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.

Flint M, Thomas JM, Maidens CM, Shotton C, Levy S, Barclay WS, McKeating JA. Flint M, et al. J Virol. 1999 Aug;73(8):6782-90. doi: 10.1128/JVI.73.8.6782-6790.1999. J Virol. 1999. PMID: 10400776 Free PMC article.

9

A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.

Donald RGK, Flint M, Kalyan N, Johnson E, Witko SE, Kotash C, Zhao P, Megati S, Yurgelonis I, Lee PK, Matsuka YV, Severina E, Deatly A, Sidhu M, Jansen KU, Minton NP, Anderson AS. Donald RGK, et al. Among authors: flint m. Microbiology (Reading). 2013 Jul;159(Pt 7):1254-1266. doi: 10.1099/mic.0.066712-0. Epub 2013 Apr 29. Microbiology (Reading). 2013. PMID: 23629868 Free PMC article.

10

The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum.

Flint M, McKeating JA. Flint M, et al. J Gen Virol. 1999 Aug;80 ( Pt 8):1943-1947. doi: 10.1099/0022-1317-80-8-1943. J Gen Virol. 1999. PMID: 10466789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters